Khandekar, Azhar
Vangara, Raviteja
Barnes, Mark
Díaz-Gay, Marcos
Abbasi, Ammal
Bergstrom, Erik N.
Steele, Christopher D.
Pillay, Nischalan
Alexandrov, Ludmil B.
Funding for this research was provided by:
Cancer Research UK (C98/A24032, C98/A24032, C98/A24032, C98/A24032, C98/A24032, C98/A24032, C98/A24032)
National Institute of Environmental Health Sciences (R01ES032547-01, R01ES032547-01, R01ES032547-01, R01ES032547-01, R01ES030993-01A1)
National Cancer Institute (R01CA269919-01, R01CA269919-01)
Article History
Received: 3 February 2023
Accepted: 14 August 2023
First Online: 21 August 2023
Declarations
:
: Not applicable.
: Not applicable.
: LBA is a compensated consultant and has equity interest in io9, LLC. His spouse is an employee of Biotheranostics, Inc. LBA is also an inventor of a US Patent 10,776,718 for source identification by non-negative matrix factorization. LBA declares U.S. provisional applications with serial numbers: 63/289,601; 63/269,033; 63/366,392; 63/367,846; 63/412,835. All other authors declare that they have no competing interests.